Ganfeng Lithium Group Valuation
Is 39EA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 39EA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 39EA (€2.91) is trading above our estimate of fair value (€0.34)
Significantly Below Fair Value: 39EA is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 39EA?
Key metric: As 39EA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 39EA's PS Ratio? | |
|---|---|
| PS Ratio | 3.8x |
| Sales | CN¥21.21b |
| Market Cap | CN¥73.07b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 5x |
| Enterprise Value/EBITDA | -43.7x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 39EA's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.3x | ||
SY1 Symrise | 3x | 5.5% | €14.6b |
EVK Evonik Industries | 0.5x | 2.2% | €8.1b |
1COV Covestro | 0.8x | 4.3% | €10.9b |
2NF Syensqo | 1.1x | 4.2% | €7.5b |
39EA Ganfeng Lithium Group | 3.8x | 14.3% | €73.1b |
Price-To-Sales vs Peers: 39EA is expensive based on its Price-To-Sales Ratio (3.8x) compared to the peer average (1.3x).
Price to Sales Ratio vs Industry
How does 39EA's PS Ratio compare vs other companies in the DE Chemicals Industry?
Price-To-Sales vs Industry: 39EA is expensive based on its Price-To-Sales Ratio (3.8x) compared to the European Chemicals industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is 39EA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 3.8x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 39EA's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Arkema
€5.6b
Manufactures and sells specialty chemicals and advanced materials worldwide.
V1S
€74.15
7D
-1.4%
1Y
-20.4%
African Rainbow Minerals
R31.4b
Through its subsidiaries, operates as a diversified mining and minerals company in South Africa, Malaysia, and Switzerland.
EB9
R8.40
7D
-1.8%
1Y
-3.4%
Cabka
€66.7m
Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.
7GW
€2.64
7D
3.9%
1Y
-57.0%